Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
MA 03 - Chemotherapy
- 11:00 - 12:30
- 10/16/2017
- Location: Room 502
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Jin-Hyoung Kang, W. Su
-
+
MA 03.01 - Nab-Paclitaxel ± CC-486 as Second-Line Treatment of Advanced NSCLC: Results from the ABOUND.2L+ Study
11:00 - 11:05 | Presenter: Ramaswamy Govindan | Author(s): D. Morgensztern, Manuel Cobo Dols, S. Ponce Aix, Pieter E. Postmus, Jaafar Bennouna, J.R. Fischer, O.J. Vidal, D.J. Stewart, G. Fasola, J. Weaver, M. Wolfsteiner, T.J. Ong
- Abstract
Loading... -
+
MA 03.02 - Timing of B12/Folate Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy: Final Results of the PEMVITASTART Randomized Trial
11:05 - 11:10 | Presenter: Navneet Singh | Author(s): M. Baldi, J. Kaur, Kuruswamy Thurai Prasad, R. Kapoor, Digambar Behera
- Abstract
Loading... -
+
MA 03.03 - Nedaplatin plus Docetaxel versus Cisplatin plus Docetaxel as First-Line Chemotherapy for Advanced Squamous Cell Carcinoma of the Lung
11:10 - 11:15 | Presenter: Shun Lu | Author(s): Z. Chen, C.P. Hu, R. Xin-Ling, Y. Chen, Yong Song, Z. Qiong, Yun Fan, W. Gang, M. Zhi-Yong, Jian Fang, Y. Qi-Tao, Z. Liu
- Abstract
Loading... -
+
MA 03.04 - Discussant - MA 03.01, MA 03.02, MA 03.03
11:15 - 11:30 | Presenter: Adrian G. Sacher
- Abstract
No abstract available for this presentation
-
+
MA 03.05 - Bevacizumab Combined with Chemotherapy for Patients with Advanced NSCLC and Brain Metastasis. A French Cohort Study
11:30 - 11:35 | Presenter: Jaafar Bennouna | Author(s): L. Falchero, R. Schott, F. Bonnetain, M. Coudert, B. Ben Hadj Yahia, C. Chouaid
- Abstract
Loading... -
+
MA 03.06 - Effect of 2L Ramucirumab after Rapid Time to Progression on 1L Therapy: Subgroup Analysis of REVEL in Advanced NSCLC
11:35 - 11:40 | Presenter: Martin Reck | Author(s): Frances A Shepherd, Maurice Pérol, Frederico Cappuzzo, J. Shih, Keunchil Park, K.B. Winfree, E. Alexandris, P. Lee, A. Sashegyi, Edward Brian Garon
- Abstract
Loading... -
+
- Abstract
Loading... -
+
MA 03.08 - Discussant - MA 03.05, MA 03.06, MA 03.07
11:45 - 12:00 | Presenter: Ikuo Sekine
- Abstract
No abstract available for this presentation
-
+
MA 03.09 - The Cost and the Benefit: Front-Line Immunotherapy for Non-Small Cell Lung Cancer
12:00 - 12:05 | Presenter: Christine M Bestvina | Author(s): Everett E Vokes, P.C. Hoffman, J. Patel
- Abstract
Loading... -
+
MA 03.10 - Prognostic Factors in NSCLC Patients Treated with a Fourth-Line Therapy
12:05 - 12:10 | Presenter: Vincent Leroy | Author(s): J. Labreuche, T. Gey, G. Terce, M.C. Willemin, X. Dhalluin, E. Wasielewski, A. Scherpereel, Alexis B Cortot
- Abstract
Loading... -
+
MA 03.11 - Targeting CDCA3 Enhances Sensitivity to Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer
12:10 - 12:15 | Presenter: Mark N Adams | Author(s): J. Burgess, D. Richard, Kenneth Obyrne
- Abstract
Loading... -
+
MA 03.12 - Discussant - MA 03.09, MA 03.10, MA 03.11
12:15 - 12:30 | Presenter: Mary Obrien
- Abstract
No abstract available for this presentation
-
+
MA 04 - Advocacy: Listen to the Patients
- 11:00 - 12:30
- 10/16/2017
- Location: Room 313 + 314
- Type: Mini Oral
- Track: Patient Advocacy
- Moderators:Rudolf M Huber, C.L. Dégi
-
+
MA 04.01 - Prospective Comparative Evaluation of Patient and Caregiver Perspectives on a Multidisciplinary Model of Lung Cancer Care
11:00 - 11:05 | Presenter: Matthew P Smeltzer | Author(s): K.D. Ward, F.E. Rugless, N.R. Faris, M.A. Ray, B. Jackson, C. Foust, A. Patel, M. Meadows, N. Boateng, K. Roark, F. Crossley, G. Oliver, L. McHugh, W. Hastings, O. Osborne, J. Osborne, T. Ill, M. Ill, R.S. Signore, R. Fox, E.T. Robbins, Raymond U. Osarogiagbon
- Abstract
Loading... -
+
MA 04.02 - Assessing the Psychosocial Needs of Newly Diagnosed NSCLC Patients: Identifying the Population Most At-Risk
11:05 - 11:10 | Presenter: Bonnie Leung | Author(s): H. Naik, J. Laskin, J. Wu, R. Mackenzie, A. Bates, C. Ho
- Abstract
Loading... -
+
MA 04.04 - Discussant - MA 04.01, MA 04.02, MA 04.03
11:10 - 11:25 | Presenter: Kathy Weber
- Abstract
No abstract available for this presentation
-
+
MA 04.05 - The Impact of the Meso Foundation on Advocacy Efforts for Funding Mesothelioma Research
11:25 - 11:30 | Presenter: M. Kotizan | Author(s): Gleneara Elizabeth Bates, J. Mostel, Mary Hesdorffer
- Abstract
Loading... -
+
MA 04.06 - Developing a Lung Cancer Clinical Quality Registry Framework to Collect Longitudinal Patient-Reported Outcomes
11:30 - 11:35 | Presenter: Mary Duffy | Author(s): N. Moloczij, K. Gough, David L Ball, Ben J Solomon, L. Mileshkin, M. Krishnasamy
- Abstract
Loading... -
+
MA 04.07 - Understanding Patient Barriers to Utilization of Low Dose CT Lung Cancer Screening
11:35 - 11:40 | Presenter: Cherie Parungo Erkmen | Author(s): F. Dako
- Abstract
Loading... -
+
MA 04.08 - Discussant - MA 04.05, MA 04.06, MA 04.07
11:40 - 11:55 | Presenter: Andrea Katalin Borondy Kitts
- Abstract
No abstract available for this presentation
-
+
MA 04.09 - A Study on the Damage of Passive Smoking to Japanese Lung Cancer Patients
11:55 - 12:00 | Presenter: Kazuo Hasegawa | Author(s): T. Yamaoka, Satoko Kono, H. Nakahara
- Abstract
Loading... -
+
MA 04.10 - An Assessment of the Willingness to Provide Serial Bio-Specimens: Experience from an Irish Tertiary Cancer Centre
12:00 - 12:05 | Presenter: Anne-Marie Baird | Author(s): N.M. Keegan, Martin P Barr, S. Fishleder, A.F. Idris, E. Harrold, P. O'Kelly, E. Duff, S. Lim, M. O'Donnell, D.J. Gallagher, C. Grant, J. Kennedy, D.M. O'Donnell, S. Sukor, C.P. O'Brien, Stephen P Finn, S. Cuffe
- Abstract
Loading... -
+
MA 04.11 - A Comprehensive Vision to Reduce Lung Cancer Stigma: Changing Cultural Perspectives on Lung Cancer
12:05 - 12:10 | Presenter: Angela Meredith Criswell | Author(s): Maureen Rigney, J.L. Studts
- Abstract
Loading... -
+
MA 04.12 - Discussant - MA 04.09, MA 04.10, MA 04.11
12:10 - 12:25 | Presenter: Sita Andarini
- Abstract
No abstract available for this presentation
-
+
MA 04.13 - Q&A
12:25 - 12:30
- Abstract
No abstract available for this presentation
-
+
MS 01 - Clinical Development of Novel Agents
- 11:00 - 12:30
- 10/16/2017
- Location: Main Hall
- Type: Mini Symposium
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:S. Mandrekar, M. Mori
-
+
MS 01.01 - Expansion Cohorts in Phase I Trials: Non Controlled Phase II or Translational Science?
11:00 - 11:20 | Presenter: Benjamin Besse
- Abstract
No abstract available for this presentation
-
+
MS 01.02 - Are We Categorizing Biomarkers Too Quickly?
11:20 - 11:40 | Presenter: Jack Lee
- Abstract
No abstract available for this presentation
-
+
MS 01.03 - Innovative Trial Designs: What is the Minimal Burden of Proof for Drug Approval?
11:40 - 12:00 | Presenter: Giuseppe Giaccone
- Abstract
No abstract available for this presentation
-
+
MS 01.04 - Is "Big Data" the Solution to the Complex Therapeutic Landscape?
12:00 - 12:20 | Presenter: Yu Shyr
- Abstract
Loading... -
+
MS 01.05 - Q&A
12:20 - 12:30
- Abstract
No abstract available for this presentation
-
+
MS 02 - Ethnic Differences: Biology or Myth
- 11:00 - 12:30
- 10/16/2017
- Location: Room 501
- Type: Mini Symposium
- Track: Regional Aspects/Health Policy/Public Health
-
+
MS 02.01 - Lung Cancer Genomics
11:30 - 11:45 | Presenter: Ramaswamy Govindan
- Abstract
Loading... -
+
MS 02.02 - Molecular Epidemiology
11:15 - 11:30 | Presenter: Tomoya Kawaguchi | Author(s): K. Sawa, N. Yoshimoto, K. Hirata, Philip Christopher Mack
- Abstract
Loading... -
+
MS 02.03 - Chemotherapy: Efficacy and Toxicity Difference According to Ethnicity
11:00 - 11:15 | Presenter: Martin Edelman
- Abstract
Loading... -
+
MS 02.04 - Targeted Agents and Immunotherapy: Efficacy and Toxicity Difference According to Ethnicity
11:45 - 12:00 | Presenter: Luis Paz-Ares
- Abstract
No abstract available for this presentation
-
+
MS 02.05 - Is Ethnicity a Prognostic Factor in Lung Cancer
12:00 - 12:15 | Presenter: Viola Zhu
- Abstract
Loading... -
+
MS 02.06 - Q&A
12:15 - 12:30
- Abstract
No abstract available for this presentation
-
+
MS 03 - Best Practice for Small-Sized Early Stage Lung Cancer: Standard Surgery, Limited Resection, SBRT
- 11:00 - 12:30
- 10/16/2017
- Location: F203 + F204 (Annex Hall)
- Type: Mini Symposium
- Track: Early Stage NSCLC
- Moderators:H.Y. Lee, Masami Sato
-
+
MS 03.01 - Limited vs. Standard Surgical Resection: North American Experience
11:00 - 11:15 | Presenter: Nasser Altorki
- Abstract
No abstract available for this presentation
-
+
MS 03.02 - Limited vs. Standard Surgical Resection: Japanese Experience
11:15 - 11:30 | Presenter: Hisao Asamura
- Abstract
Loading... -
+
MS 03.03 - Limited vs. Standard Surgical Resection: European Experience
11:30 - 11:45 | Presenter: Paul Emile Van Schil
- Abstract
Loading... -
+
MS 03.04 - Technical Aspects of Limited Resection
11:45 - 12:00 | Presenter: Harvey I Pass
- Abstract
Loading... -
+
MS 03.05 - SBRT Experience
12:00 - 12:15 | Presenter: Joe Y Chang
- Abstract
Loading... -
+
MS 03.06 - Q&A
12:15 - 12:30
- Abstract
No abstract available for this presentation
-
+
MS 04 - Joint IASLC/GLCC Session Current Issues in Lung Cancer Advocacy
- 11:00 - 12:30
- 10/16/2017
- Location: Room 316
- Type: Mini Symposium
- Track: Patient Advocacy
- Moderators:Natasha B Leighl, Maureen Rigney
-
+
MS 04.01 - Lung Cancer Advocacy Tools for Everyone - The Use of GLCC Data
11:00 - 11:15 | Presenter: Jesme Fox
- Abstract
Loading... -
+
MS 04.02 - Lung Cancer Advocates and Measuring Value in Healthcare
11:15 - 11:30 | Presenter: Carolyn Aldige
- Abstract
Loading... -
+
MS 04.03 - Accessing New Lung Cancer Therapies - Challenges & Experience in Latin America
11:30 - 11:45 | Presenter: Mirna Patricia Mondragon
- Abstract
Loading... -
+
MS 04.04 - Patient Advocacy - Making a Difference for Lung Cancer Patients in Japan
11:45 - 12:00 | Presenter: Toshiyuki Sawa
- Abstract
Loading... -
+
MS 04.05 - Lung Cancer Patients and Stopping Smoking - What Advocates Need to Know
12:00 - 12:15 | Presenter: Aoife McNamara
- Abstract
Loading... -
+
MS 04.06 - Q&A
12:15 - 12:30
- Abstract
No abstract available for this presentation
-
+
OA 01 - The New Aspect of Radiation Therapy
- 11:00 - 12:30
- 10/16/2017
- Location: F201 + F202 (Annex Hall)
- Type: Oral
- Track: Radiotherapy
- Moderators:M. Hiraoka, S.H. Kim
-
+
OA 01.01 - A Randomized Trial of SABR vs Conventional Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: TROG 09.02 (CHISEL)
11:00 - 11:10 | Presenter: David L Ball | Author(s): T. Mai, S.K. Vinod, S. Babington, J.D. Ruben, T. Kron, B. Chesson, A. Herschtal, A. Rezo, C. Elder, M. Skala, A. Wirth, G. Wheeler, A. Lim, M. Vanevski, M. Shaw
- Abstract
Loading... -
+
OA 01.02 - Stereotactic Radiotherapy as Salvage Treatment After Surgery and Curative Intended Radiotherapy for Patients with NSCLC
11:10 - 11:20 | Presenter: Olfred Hansen | Author(s): C. Kristiansen, Stefan Starup Jeppesen, T.B. Nielsen, T. Schytte, M. Nielsen
- Abstract
Loading... -
+
OA 01.03 - Patterns of Change in High-Risk Radiological Features in Patients without Local Recurrence after SABR for Early-Stage NSCLC
11:20 - 11:30 | Presenter: Merle Ilona Ronden
- Abstract
Loading... -
+
OA 01.04 - Discussant - OA 01.01, 01.02, OA 01.03
11:30 - 11:45 | Presenter: Jin Hee Kim
- Abstract
No abstract available for this presentation
-
+
OA 01.05 - Analysis of Radiotherapy Quality Assurance Data for the Convert Trial - Does Non-Compliance to Protocol Affect Survival?
11:45 - 11:55 | Presenter: Elena Wilson | Author(s): N. Groom, Corinne Faivre-Finn
- Abstract
Loading... -
+
OA 01.06 - Radiation Therapy is Associated with an Increased Incidence of Cardiac Events in Small Cell Lung Cancer Patients
11:55 - 12:05 | Presenter: Matthew Jeffrey Ferris | Author(s): R. Jiang, K. Ward, Suresh S Ramalingam, M. Behera, Kristin A Higgins
- Abstract
Loading... -
+
OA 01.07 - Tracking Major Symptom Burden from Chemotherapy Concurrent with 3D vs. IMRT vs. Proton Beam Radiotherapy for NSCLC
12:05 - 12:15 | Presenter: Qiuling Shi | Author(s): X.S. Wang, Z. Liao, George R. Simon, C.S. Cleeland
- Abstract
Loading... -
+
OA 01.08 - Discussant - OA 01.05, OA 01.06, OA 01.07
12:15 - 12:30 | Presenter: Yukinori Matsuo
- Abstract
No abstract available for this presentation
-
+
OA 02 - Mesothelioma: Challenges For New Treatment
- 11:00 - 12:30
- 10/16/2017
- Location: F205 + F206 (Annex Hall)
- Type: Oral
- Track: Mesothelioma
- Moderators:S. Hasegawa, Anna Nowak
-
+
OA 02.01 - Randomized Phase II Study of Anetumab Ravtansine or Vinorelbine in Patients with Malignant Pleural Mesothelioma
11:00 - 11:10 | Presenter: Hedy Lee Kindler | Author(s): Silvia Novello, Dean A Fennell, G. Blumenschein, A. Bearz, G.L. Ceresoli, J.G. Aerts, J. Spicer, P. Taylor, A. Greystoke, K. Nackaerts, Luana Calabro, S. Burgers, R. Jennens, A.F. Sporchia, A. Walter, J. Siegel, B.H. Childs, C. Elbi, R. Hassan
- Abstract
Loading... -
+
OA 02.02 - Ipilimumab and Nivolumab in the Treatment of Recurrent Malignant Pleural Mesothelioma: A Phase II Study
11:10 - 11:20 | Presenter: Paul Baas | Author(s): M. Disselhorst, E. Harms, H. Van Tinteren, J. Quispel-Janssen, K. Monkhorst, S. Burgers
- Abstract
Loading... -
+
OA 02.03 - Prophylactic Irradiation of Tracts (PIT) in Patients with Pleural Mesothelioma: Results of a Multicentre Phase III Trial
11:20 - 11:30 | Presenter: Corinne Faivre-Finn | Author(s): Neil Bayman, W. Appel, L. Ashcroft, David Raymond Baldwin, A. Bates, Liz Darlison, J.G. Edwards, V. Ezhil, D. Gilligan, M. Hatton, T. Mansy, M.D. Peake, L. Pemberton, Robert Campbell Rintoul, D.J. Ryder, P. Taylor
- Abstract
Loading... -
+
OA 02.04 - Discussant - OA 02.01, OA 02.02, OA 02.03
11:30 - 11:45 | Presenter: Daniel H. Sterman
- Abstract
No abstract available for this presentation
-
+
OA 02.05 - RESPECT-MESO: An International Randomised Controlled Trial to Assess Early Specialist Palliative Care in Malignant Pleural Mesothelioma
11:45 - 11:55 | Presenter: Fraser Brims | Author(s): S. Gunatilake, I. Lawrie, L. Marshall, C. Fogg, N. Maskell, K. Forbes, N. Rahman, S. Morris, S. Gerry, A. Chauhan
- Abstract
Loading... -
+
OA 02.06 - Radioimmunotherapy Combining CTLA-4 Blockade or Low-Dose Cyclophosphamide with Local Radiation in Murine Malignant Mesothelioma
11:55 - 12:05 | Presenter: Mikihiro Kohno | Author(s): L. Wu, L. De La Maza, Z. Yun, M. Chan, Y. Yao, Y. Zhao, Marc De Perrot
- Abstract
Loading... -
+
OA 02.07 - Surgical Selection in Pleurectomy Decortication for Mesothelioma – an Overview from Screening and Selection from MARS 2 Pilot
12:05 - 12:15 | Presenter: Eric Lim | Author(s): M. Trialists
- Abstract
Loading... -
+
OA 02.08 - Discussant - OA 02.05, OA 02.06, OA 02.07
12:15 - 12:30 | Presenter: Prasad S. Adusumilli
- Abstract
No abstract available for this presentation
-
+
OA 03 - Mediastinal and Esophageal Tumor: Insight and New Treatment
- 11:00 - 12:30
- 10/16/2017
- Location: Room 311 + 312
- Type: Oral
- Track: Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Moderators:M. Chida, Jhingook Kim
-
+
OA 03.01 - Prevalence of Autoimmune Diseases in Thymic Epithelial Tumors (TET) Insights from RYTHMIC
11:00 - 11:10 | Presenter: Marie-Eve Boucher | Author(s): E. Dansin, M. Kerjouan, Julien Mazieres, E. Pichon, F. Thillays, G. Massard, X. Quantin, O. Youssef, Virginie Westeel, L. Thiberville, C. Clement-Duchene, F. Morin, P. Thomas, Nicolas Girard, Benjamin Besse
- Abstract
Loading... -
+
OA 03.02 - Comprehensive Characterization of Thymic Epithelial Tumour Subtypes Through an Analysis of Somatic Mutations and Copy Number Alterations
11:10 - 11:20 | Presenter: Spyridon Gennatas | Author(s): A. Mandal, Andrew G Nicholson, Sanjay Popat, A.M. Bowcock
- Abstract
Loading... -
+
OA 03.03 - Phase II Trial of Cetuximab and Chemotherapy Followed by Surgical Resection for Locally Advanced Thymoma
11:20 - 11:30 | Presenter: James Huang | Author(s): D.J. Raz, M. Cristea, Kay See Tan, K. Deonaraine, A. Starr, William D Travis, M.S. Ginsberg, D. Jones, Valerie W Rusch, Mark G Kris, Gregory J Riely
- Abstract
Loading... -
+
OA 03.04 - A Phase II Study of Pembrolizumab for Patients with Refractory or Relapsed Thymic Epithelial Tumor
11:30 - 11:40 | Presenter: Jinhyun Cho | Author(s): K.H. Yoo, Hansang Lee, H.K. Kim, Y. Kim, J.H. Cho, S.W. Lim, Song Ee Park, Jong-Mu Sun, S. Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
- Abstract
Loading... -
+
OA 03.05 - Discussant - OA 03.01, OA 03.02, OA 03.03, OA 03.04
11:40 - 11:55 | Presenter: Masanori Tsuchida
- Abstract
No abstract available for this presentation
-
+
OA 03.06 - Clinicopathologic, Immunophenotypic and Genetic Studies of Mediastinal Paragangliomas
11:55 - 12:05 | Presenter: Anja C Roden | Author(s): Y. Hsu, B. Kipp, S. Jenkins, W. Sukov, H. Schaff, S. Cassivi, J. Torres-Mora
- Abstract
Loading... -
+
- Abstract
Loading... -
+
OA 03.08 - Discussant - OA 03.06, OA 03.07
12:15 - 12:30 | Presenter: Nicolas Girard
- Abstract
No abstract available for this presentation
-
+
ES 03 - Current Topics for Nurses & Allied Health
- 15:45 - 17:30
- 10/16/2017
- Location: Room 313 + 314
- Type: Educational Session
- Track: Nursing/Palliative Care/Ethics
- Moderators:Anne Fraser, S. Kim
-
+
ES 03.01 - IASLC Immunotherapy Guidelines
15:45 - 16:05 | Presenter: Kimberly Ann Rohan
- Abstract
Loading... -
+
ES 03.02 - Pulmonary Rehabilitation
16:05 - 16:25 | Presenter: Catherine L Granger
- Abstract
Loading... -
+
ES 03.03 - Allied Health: The Missing Link in Comprehensive Cancer Care
16:25 - 16:45 | Presenter: Kahren White
- Abstract
Loading... -
+
ES 03.04 - Mesothelioma: Beyond the Basics
16:45 - 17:05 | Presenter: Mary Hesdorffer | Author(s): Gleneara Elizabeth Bates
- Abstract
Loading... -
+
ES 03.05 - Case Presentation
17:05 - 17:25 | Presenter: Yun Hee Ham
- Abstract
No abstract available for this presentation
-
+
ES 03.06 - Q&A
17:25 - 17:30
- Abstract
No abstract available for this presentation